How To | Cost of Care

Evaluating Cost-of-Care Progress

How To | Cost of Care

Evaluating Cost-of-Care Progress

Although more time and evidence are needed to prove the efficacy of population-based VBP models, there are other models that may be more appropriate for different populations.

In an analysis of factors that may be influencing total cost of care in U.S. healthcare markets, researchers from HFMA, Leavitt Partners, and McManis Consulting report the following:

  • The penetration of population-based value-based payment (VBP) models is not yet having an impact on curbing growth in total cost of care. The cost efficacy of these models has not yet been proven, however, even in markets where these models are more prevalent, most models do not yet incorporate sufficient financial incentives to impact care delivery significantly.
  • Although more time and evidence are needed to prove the efficacy of population-based VBP models, there are other models that may be more appropriate for different populations. Alternative VBP models of interest to stakeholders interviewed for this study include episode-based payments, reference-based pricing, on-site health centers for employers and their employees, consumer-driven models tied to more effective transparency tools, and models that target the needs of specific patient populations.
  • The question of “what type” of competition may be more important than “how much” competition. Lower-cost markets appear to benefit from competition among healthcare systems with well-organized provider networks and geographic coverage across their markets. Health plan competition also appears to be a significant factor, especially in encouraging payment model and plan design innovation.
  • Lower-cost markets appear to benefit from organized mechanisms, including state-sponsored or endorsed reporting agencies and employer coalitions, for sharing provider quality and costs.

To access the report or executive summary, visit hfma.org/tcoc.

Sign up for a free guest account and get access to five free articles every month.

Advertisements

Related Articles | Cost of Care

Column | Leadership

Healthcare’s top area of vulnerability: What finance leaders need to know

HFMA President and CEO Joseph J. Fifer discusses recent survey findings that cost effectiveness is not only a weak spot for hospitals and health systems but also healthcare’s No. 1 area of vulnerability to disruption.

Business Profile | Revenue Cycle Technology

Strategic partnership: The key to improved patient experience and revenue cycle outcomes

One company shares advice and trends in addition to how its service offerings can hep healthcare organizations facing challenges, the biggest being people, process and technology.

Article | Patient Access

Health Services Financing helps providers offer all patients a touchless financing program

One company uses its patient financing program to address patient access to care and the rising cost of healthcare, two of healthcare’s biggest challenges.

News | Price Transparency

Healthcare price transparency initiatives may fall flat due to systemic factors, expert says

Niall Brennan, a leading expert on healthcare cost drivers, is among the skeptics who doubt the ongoing price transparency push can result in a more efficient system.